Efficacy of tolterodine in relation to different urodynamic findings of detrusor overactivity

International Urogynecology Journal

Volumn 19, Issue 5, 2008, Pages 701-704

  Salvatore, Stefano ^a   Serati, Maurizio ^a   Digesu, G Alessandro ^b   Triacca, Paola ^a   Uccella, Stefano ^a   Khullar, Vik ^c   Bolis, Pier Francesco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b V BUZZI CHILDREN S HOSPITAL   (Italy)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TOLTERODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOMETRY; DEMOGRAPHY; DETRUSOR MUSCLE; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; URODYNAMICS; XEROSTOMIA;

EID: 42049084409     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-007-0512-8     Document Type: Article

References (16)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 21:167-178
2. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 50:1306-14 (discussion 1314-1315)
3. Abrams P, Andersson KE, Brubaker L, Cardozo L (2005) Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence, 3rd International Consultation on Incontinence. Plymbridge Distributors Ltd., Plymouth, UK, pp 1606-1608
4. Hay-Smith J, Herbison P, Ellis G, Morris A. (2005) Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev. Issue 3
5. Chapple C, Khullar V, Gabriel Z, Dooley JA (2005) The effects of antimuscarinic treatments in Overactive Bladder: A systematic review and meta-analysis. Eur Urol 48:5-26
6. Elinoff V, Bavendam T, Glasser DB, Carlsson M, Eyland N, Roberts R (2006) Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: The IMPACT trial. Int J Clin Pract 60:745-751
7. Morrison J, Steers WD, Brading A, Blok B, Fry C, DeGroat WC, Kakizaki H, Levin R, Thor K (2002) Neurophysiology and neuropharmacology. In: Abrams P, Khoury S, Wein A (eds) Incontinence, 2nd International Consultation on Incontinence. Plymbridge Distributors Ltd., Plymouth, UK, p 5
8. Anderson KE (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45:253-308
9. Andersson KE (1992) Clinical pharmacology of potassium channel openers. Pharmacol Toxicol 70:244-254
10. Igawa Y, Yamazaki Y, Takeda H, Hayakawa K, Akahane M, Ajisawa Y (1999) Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 126:819
11. Andersson KE, Appel R, Awad S, Chapple C, Drutz H, Fourcroy J (2002) Pharmacological treatment of urinary incontinence. In: Abrams P, Khoury S, Wein A (eds) Incontinence, 2nd International Consultation on Incontinence. Plymbridge Distributors Ltd., Plymouth, UK, p 479
12. Szallasi A (1994) The vanilloid (capsaicin) receptor: Receptor types and species differences. Gen Pharmacol 25:223
13. Digesu GA, Khullar V, Cardozo L, Salvatore S (2003) Overactive bladder symptoms: Do we need urodynamics? Neurourol Urodyn 22:105-108
14. Digesu GA, Hutchings A, Salvatore S, Selvaggi L, Khullar V (2003) Pressure flow parameters in female: Reliability studies. BJOG 110:774-776
15. Schafer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P (2002) Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261-274
16. Burgio KL, Goode PS, Richter HE, Locher JL, Roth DL (2006) Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: Validation of three global patient ratings. Neurourol Urodyn 25:411-417